undefined undefined
NaN.000
NaN.00%
cbdMD, Inc. (NYSE: YCBD) announced its financial results for the second quarter of fiscal 2024, ending March 31, 2024. Despite an increase in operational losses from $1.4 million in Q2 fiscal 2023 to $1.5 million in Q2 fiscal 2024, management remains optimistic.
05-16 06:07
cbdMD press release (NYSE:YCBD): Q2 GAAP EPS of -$1.35. Revenue of $4.4M (-29.0% Y/Y). More on cbdMD Seeking Alpha’s Quant Rating on cbdMD Historical earnings data for cbdMD Financial information for ...
05-16 05:29
Gainers: CytomX Therapeutics (CTMX) +163%. SYLA Technologies Co., Ltd. (SYT) +.42%. New York Community Bancorp (NYCB) +32%. Surmodics (SRDX) +32%. TransMedics Group (TMDX) +27%. DecisionPoint Systems ...
05-02 01:00
Cannabis-related stocks rose sharply higher in afternoon trading Tuesday after The Associated Press reported that the U.S. drug control agency, the Drug Enforcement Administration (DEA), is set to rec...
05-01 02:15
文章转载来源: 白话区块链 作者:@DefiIgnas 翻译:白话区块链 比特币减半和符文上线已经完成,接下来是 Stacks Nakamoto 升级。以下是为...
04-25 09:40
GAINERS: Cansortium (OTC:CNTMF) shares closed up 27.27% at $0.14 Global Hemp G...
01-23 05:30
https://twitter.com/cbdmd_usa/status/1742980509930545164
01-05 02:49
GAINERS: Psychemedics (NASDAQ:PMD) shares closed up 17.17% at $3.89 22nd Cent...
2023-10-07 05:30
What is the target price for cbdMD (YCBD)? The latest price target for cbdMD...
2023-10-05 23:37
Gainers Acer Therapeutics Inc. (NASDAQ: ACER) shares jumped 145% to $1.4850 after Zevra Therapeutics announced it will acquire the company. The transaction will have a total potential value for Acer stockholders of up to $91 million.
2023-09-01 00:50